|
|
Volumn 31, Issue 2-3, 2005, Pages 365-380
|
|
Potential interactions of the Orphan Drug Act and pharmacogenomics: A flood of orphan drugs and abuses?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
NEW DRUG;
PENTAMIDINE;
ZIDOVUDINE;
CLINICAL TRIAL;
COST;
DRUG ABUSE;
DRUG LABELING;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG MECHANISM;
DRUG RESEARCH;
DRUG SURVEILLANCE PROGRAM;
FINANCIAL MANAGEMENT;
LAW;
LEGAL ASPECT;
PHARMACOGENETICS;
PHARMACOGENOMICS;
PRACTICE GUIDELINE;
REVIEW;
UNITED STATES;
|
|
EID: 23944501764
PISSN: 00988588
EISSN: None
Source Type: Journal
DOI: 10.1177/009885880503100210 Document Type: Review |
|
Times cited : (39)
|
|
References (0)
|